einstein (São Paulo). 08/Apr/2021;19:eCE6285.

Infection of red blood cells by SARS-CoV-2: new evidence

Uzzam Ahmed , Erfan , Lorenzo Ferro , Marcos Roberto

DOI: 10.31744/einstein_journal/2021CE6285

Dear Editor,

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) corresponds to a new coronavirus subtype, which was first identified in December 2019 in Wuhan City, Hubei Province, China. This virus is the causative agent of the current pandemic, whose associated disease was named coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). Thenceforward, SARS-CoV-2 has spread quickly across almost all countries and it has caused various economic and social impacts, affecting globally the health systems and the routine of the population. Despite this, so far, no specific drugs have been made available for intervention and treatment of COVID-19 patients.()

[…]

Infection of red blood cells by SARS-CoV-2: new evidence
Skip to content